English | Español
Jamie Barrand | Nov 22, 2015

FDA approves Ninlaro for patients with multiple myeloma
Jamie Barrand | Nov 20, 2015

'Your Time' campaign to increase awareness of chronic obstructive pulmonary disease
Jamie Barrand | Nov 20, 2015

ACA allows over $2.4 billion in rebates to return to health insurance consumers since 2011
Jamie Barrand | Nov 20, 2015

National Institutes of Health studies link between Alzheimer's and Down syndrome
Jamie Barrand | Nov 20, 2015

AbbVie's hepatitis C drug study sees positive results
Jamie Barrand | Nov 20, 2015

NORD backs Robert Califf as next FDA commissioner
Kerry Goff | Nov 19, 2015

Get Smart About Antibiotics Week puts spotlight on drug resistance
Jamie Barrand | Nov 19, 2015

U.S. Subcommittee on Health convenes to discuss 21st Century Cures Initiative

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’